���ϳԹ���

���ϳԹ��� ranks No. 38 worldwide for the number of U.S. Utility Patents awarded to the university and its researchers, according to 2023 data compiled by the U.S. Patent and Trademark Office (USPTO). The ranking places ���ϳԹ��� among the elite research universities...

Using technology created at ���ϳԹ���, Afference is ‘redefining human experiences through artificial sensation’

Funding supports newly published findings showing some medications trigger ‘cell blasters’ to kill cancer

A robotic conduit that pulls itself through the ground reduces excavation

���ϳԹ��� senior to showcase Asclepii at the prestigious festival’s 15th annual pitch competition

This article originally appeared in the fall/winter 2023 edition of Think magazine. This semester, The Daily will share some of the articles from the latest edition of the magazine. View more stories at case.edu/think. Nearly a year ago, on Feb. 3, just before 9 p.m., Ashley McCollum heard a loud b...

Researchers at ���ϳԹ��� are developing ways to convert waste into fuels and other products, using processes that are energy efficient and powered by renewable sources. More specifically, they’re close to resolving the challenge of converting carbon dioxide (CO2), a major gre...

Diagnosing cancer today involves using chemical “contrast agents” to improve the accuracy of medical imaging processes such as X-rays as well as computed tomography (CT) and magnetic resonance imaging (MRI) scans. But those agents can be expensive, take more time to use and pose potential health c...

Electrochemistry innovator and pioneering physician join 20 others from ���ϳԹ��� who have been appointed during past decade

A groundbreaking study by researchers at ���ϳԹ��� suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC). The findings, published today (Dec. 7) in the journal JAMA Oncology, support the need for clinical trials to de...